[go: up one dir, main page]

WO2004103291A3 - Compositions d'inhibiteurs de pompe a protons a liberation prolongee - Google Patents

Compositions d'inhibiteurs de pompe a protons a liberation prolongee Download PDF

Info

Publication number
WO2004103291A3
WO2004103291A3 PCT/US2004/015076 US2004015076W WO2004103291A3 WO 2004103291 A3 WO2004103291 A3 WO 2004103291A3 US 2004015076 W US2004015076 W US 2004015076W WO 2004103291 A3 WO2004103291 A3 WO 2004103291A3
Authority
WO
WIPO (PCT)
Prior art keywords
extended release
proton pump
pump inhibitor
release compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/015076
Other languages
English (en)
Other versions
WO2004103291A2 (fr
Inventor
Ray Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of WO2004103291A2 publication Critical patent/WO2004103291A2/fr
Publication of WO2004103291A3 publication Critical patent/WO2004103291A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions à libération prolongée comprenant au moins un inhibiteur de pompe à protons. L'invention concerne également des méthodes permettant de traiter des troubles gastro-intestinaux par administration des compositions de l'invention à des patients ayant besoin d'une thérapie gastro-intestinale.
PCT/US2004/015076 2003-05-16 2004-05-13 Compositions d'inhibiteurs de pompe a protons a liberation prolongee Ceased WO2004103291A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47087603P 2003-05-16 2003-05-16
US60/470,876 2003-05-16
US48574403P 2003-07-10 2003-07-10
US60/485,744 2003-07-10

Publications (2)

Publication Number Publication Date
WO2004103291A2 WO2004103291A2 (fr) 2004-12-02
WO2004103291A3 true WO2004103291A3 (fr) 2005-03-24

Family

ID=33479266

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/015076 Ceased WO2004103291A2 (fr) 2003-05-16 2004-05-13 Compositions d'inhibiteurs de pompe a protons a liberation prolongee

Country Status (1)

Country Link
WO (1) WO2004103291A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3386507T1 (sl) 2015-12-08 2023-10-30 Luoda Pharma Limited Postopki in sestavki za zdravljenje gastričnih razjed
CN114099471B (zh) * 2021-11-03 2023-01-06 海南海灵化学制药有限公司 一种奥美拉唑肠溶微丸及其制备工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548083B1 (en) * 1997-08-11 2003-04-15 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548083B1 (en) * 1997-08-11 2003-04-15 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention

Also Published As

Publication number Publication date
WO2004103291A2 (fr) 2004-12-02

Similar Documents

Publication Publication Date Title
WO2007127474A3 (fr) Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase
MY191349A (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
TW200602048A (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of β -secretase
UA85559C2 (en) Aminobenzophenone compounds
TNSN07111A1 (en) Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity.
WO2004078116A3 (fr) Inhibiteurs de la p 38 et leurs procedes d'utilisation
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
WO2006020722A3 (fr) Compositions pharmaceutiques de beta-lapachone et d'analogues de beta-lapachone possedant un potentiel de ciblage de tumeur ameliore
WO2005046603A3 (fr) Composes pyridiniques
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
WO2004074243A3 (fr) Heterocyclyl-3-sulfonylindazoles utilises comme ligands de la 5-hydroxytryptamine-6
WO2008097924A3 (fr) Compositions pharmaceutiques comprenant des analogues du dextrométhorphane pour le traitement de troubles neurologiques
WO2005004808A3 (fr) Composes tetracycliques utilises comme inhibiteurs de c-met
WO2006050058A3 (fr) Methodes de detection et de therapie de tissus enflammes par immunomodulation
ZA200709072B (en) Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
WO2006055352A3 (fr) Methodes de traitement du cancer avec des formulations de composes de platine a base lipipique administrees par voie intraperitoneale
WO2004073615A3 (fr) Composes de deazaflavine et leurs methodes d'utilisation
WO2007130501A3 (fr) Polythérapie pour traiter le cancer
WO2004098599A3 (fr) Agents pour le traitement de troubles du bas-ventre
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
WO2007014943A3 (fr) Traitement pour maladies neurologiques
WO2007056236A3 (fr) Methodes de traitement anticancereux avec des formulations d'un compose de platine a base de lipides administree par voie intraveineuse
WO2004103291A3 (fr) Compositions d'inhibiteurs de pompe a protons a liberation prolongee
WO2006042277A3 (fr) Compositions a liberation prolongee d'inhibiteurs de pompes a protons

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase